The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...
Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...
The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...
The CEO of Pfizer received loud boos when he was introduced by Donald Trump at a Black History Month event at the White House ...
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
The outrageous health claims peddled by Robert F Kennedy jr PODCAST: Why big pharma is terrified of RFK appointment. Listen nowThey might not seem like natural allies, but RFK Jr and the boss of ...
While the exact date of the meeting was not disclosed, Bourla said he and the health secretary nominee chatted civilly, conversing on topics they agreed on rather than straying to more divisive ...
Kennedy Jr. In a Tuesday earnings call, CEO Albert Bourla said Trump had introduced ... childhood vaccines if elected president. And in May 2021, he was one of two people who jointly petitioned ...
Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's "radical" changes.
CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing transformative changes.’ News Today's news ...